A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight | MicrobiomeTrials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09-28Est. Completion: 2027-06
Enrollment target: 144 participants
Locations
Ascletis Clinical Site, San Antonio, Texas, United States
Ascletis Clinical Site, Salt Lake City, Utah, United States